Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2) (VIEWS-2)

March 15, 2024 updated by: George Hornby, Indiana University

Variable Intensive Early Walking Post-Stroke -2 (VIEWS-2)

The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.

Study Overview

Detailed Description

The objective of this Phase II clinical trial is to identify how exercise training parameters, particularly the specificity and intensity of stepping practice, influence long-term mobility outcomes in patients with subacute stroke. Previous work indicates these variables can influence the efficacy of training interventions in individuals without neurological injury, with some data to support their utility in chronic stroke. However, studies that systematically assess the independent and combined effects of these principles in individuals early following stroke are sparse. This critical research gap impedes clinical translation, and current clinical practices remain adherent to traditional theories of rehabilitation, including lower intensity interventions focused on underlying impairments. Additional concerns of providing only high-intensity walking training revolve around the lack of attention toward movement quality will result in use of compensatory movement strategies that could be reinforced with repeated practice, or that other risks of cardiovascular events should preclude high-intensity training. Unfortunately, there is little data to support these hypotheses, and our studies suggest that application of these training parameters can strongly influence walking function, as well as improve underlying impairments and improve gait kinematics. Our approach is to characterize the effects of these training variables on recovery of locomotor function and quality, as well as changes in impairments and other mobility tasks in patients early post-stroke, in an effort to evaluate whether such training influences neurological recovery or whether patients utilize compensatory strategies. In this 2x2 factorial RCT design, Aim 1 of the study will characterize changes in mobility function associated with manipulation of specific and intensity of exercise interventions. We will evaluate functional measures of gait speed and endurance, spatiotemporal symmetry, as well as measures of cardiopulmonary fitness. We postulate that combined application of high-intensity, task specific stepping practice will result in significantly greater increases in locomotor measures as compared to lower intensity or non-specific training paradigms. In Aim 2, we will characterize the changes in impairments (strength) and other mobility tasks (balance, sit-to-stand transfers) to determine whether stepping intervention can mitigate the major impairments underlying post-stroke impairments. Quantitative measures of volitional strength will be the primary outcomes. In Aim 3, we will characterize changes in community mobility and quality of life, the later of which can inform us about cost-effectiveness. Overall, these results have potential implications on the delivery of effective exercise interventions in person with subacute stroke.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46254
        • Recruiting
        • Rehabilitation Hospital of Indiana
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Sub-acute stroke (1-6 months)
  • Hemiparesis (Fugl-Meyer <34) without cerebellar deficits
  • Ability to ambulate with or without physical assistance over 10 meters but < 1.0 m/s and assistive devices and below-knee bracing is allowed.
  • Ability to sit > 30 seconds without upper-extremity support or physical assistance
  • Ability to follow 3-step commands
  • Provision of informed consent and medical clearance from a supervising physician or medical provider to participate
  • Must have the ability to consent or have a legal health care power of attorney or legally authorized representative to consent for participation on their behalf

Exclusion Criteria:

  • Significant cardiovascular, metabolic, or respiratory disease that limits exercise participation (e.g. previous myocardial infarction < 3 months prior, uncompensated congestive heart failure, resting blood pressure > 210/110 mmHg, uncontrolled diabetes, end-stage renal disease, severe infectious or psychiatry disease, or advanced malignancy)
  • If during the graded-treadmill exercise evaluation, the participant presents with absolute criteria for termination of exercise testing during initial testing (e.g. moderate to severe angina, ST elevation > 1.0mm without preexisting Q wave secondary to prior MI, signs of poor perfusion, etc).
  • Any orthopedic or neurological disorders that limited walking to <50m prior to stroke onset.
  • Cannot receive physical therapy once baseline testing begins
  • If patients are prescribed botulinum toxin for their lower extremities will be excluded only if the dosage for any specific muscle is >50 units in leg muscles above the knee. If doses are > than 50 units in leg muscles below the knee, the participant will use an ankle-foot orthosis to minimze contributions of those mscles to locomotor function.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: High-intensity, non-specific physical therapy interventions
30 1-hr sessions of general physical therapy interventions (strengthening, balance training, aerobic cycling, transfers, walking) targeting higher cardiovascular intensities over approximately 2 months
Up to 30 1-hr sessions of training focused on varied physical interventions trying to achieve higher cardiovascular intensities
Active Comparator: Low-intensity, task-specific physical therapy interventions
30 1-hr sessions of general physical therapy interventions (strengthening, balance training, aerobic cycling, transfers, walking) targeting lower cardiovascular intensities over approximately 2 months
Up to 30 1-hr sessions of training focused on walking trying to achieve lower cardiovascular intensities
Active Comparator: Low-intensity, non-specific physical therapy interventions
30 1-hr sessions of general physical therapy interventions (strengthening, balance training, aerobic cycling, transfers, walking) targeting lower cardiovascular intensities over approximately 2 months
Up to 30 1-hr sessions of training focused on varied physical interventions trying to achieve lower cardiovascular intensities
Experimental: High-intensity, task-specific (i.e., walking) interventions
30 1-hour (hr) sessions of walking training targeting higher cardiovascular intensities over approximately 2 months
Up to 30 1-hr sessions of training focused on walking trying to achieve higher cardiovascular intensities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in gait speed
Time Frame: Approximately 8-10 weeks
Changes in gait speed over 6 m from baseline to post-training
Approximately 8-10 weeks
Changes in 6 minute walk test
Time Frame: Approximately 8-10 weeks
Changes in 6 min walk test from baseline to post-training
Approximately 8-10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in community mobility
Time Frame: Approximately 8-10 weeks
Changes in daily stepping (steps/day) from baseline to post-training
Approximately 8-10 weeks
Changes in measures of physical participation
Time Frame: Approximately 8-10 weeks
Changes in Medical Outcomes Short Form -36 questions from baseline to post-training
Approximately 8-10 weeks
Changes in gait biomechanics
Time Frame: Approximately 8-10 weeks
Changes in gait biomechanics (spatiotemporal and joint kinematics and kinetics) from baseline to post-training
Approximately 8-10 weeks
Changes in peak metabolic capacity (VO2peak) during peak treadmill speed
Time Frame: Approximately 8-10 weeks
Changes in peak metabolic capacity (VO2peak) during peak treadmill speed from baseline to post-training
Approximately 8-10 weeks
Changes in peak treadmill speed during the graded-exercise test
Time Frame: Approximately 8-10 weeks
Changes in peak treadmill speed during the graded-exercise test from baseline to post-testing
Approximately 8-10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: George Hornby, Indiana University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2023

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

February 6, 2023

First Submitted That Met QC Criteria

February 6, 2023

First Posted (Actual)

February 14, 2023

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IU-16767
  • 1R01HD108622 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Currently Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on High-intensity, task-specific (i.e., walking) interventions

3
Subscribe